Publications by authors named "Timothy P Labranche"

Claim this Profile
A
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva.
Alison J Davis, Natasja Brooijmans, Jason D Brubaker, Faith Stevison, Timothy P LaBranche

Sci Transl Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma.
Stefanie S Schalm, Erin O'Hearn, Kevin Wilson, Timothy P LaBranche, Grace Silva

Gastro Hep Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat Model.
Timothy P LaBranche, Anna K Kopec, Srinivasa R Mantena, Brett D Hollingshead, Andrew W Harrington

Toxicol Pathol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A precision therapy against cancers driven by mutations.
Erica K Evans, Alexandra K Gardino, Joseph L Kim, Brian L Hodous, Adam Shutes, Timothy P LaBranche

Sci Transl Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model.
Timothy P LaBranche, Alison M Bendele, Brian C Omura, Kathryn E Gropp, Susan I Hurst

Ann Rheum Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia.
Joseph F Nabhan, Kristy M Wood, Varada P Rao, Jeffrey Morin, Surya Bhamidipaty, Timothy P LaBranche

Sci Rep· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo imaging implicates CCR2(+) monocytes as regulators of neutrophil recruitment during arthritis.
Baomei Wang, Bernd H Zinselmeyer, Herbert A Runnels, Timothy P LaBranche, Phillip A Morton

Cell Immunol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production.
Timothy P LaBranche, Michael I Jesson, Zaher A Radi, Chad E Storer, Julia A Guzova

Arthritis Rheum· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells.
Yijun Carrier, Matthew J Whitters, Joy S Miyashiro, Timothy P LaBranche, Hilda E Ramon

Eur J Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).
Kamran Ghoreschi, Michael I Jesson, Xiong Li, Jamie L Lee, Sarbani Ghosh, Timothy P LaBranche

J Immunol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th17 cells can provide B cell help in autoantibody induced arthritis.
Cynthia L Hickman-Brecks, Jennifer L Racz, Debra M Meyer, Timothy P LaBranche, Paul M Allen

J Autoimmun· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis.
Jeffrey D Peterson, Timothy P Labranche, Kristine O Vasquez, Sylvie Kossodo, Michele Melton

Arthritis Res Ther· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K/BxN mouse.
Timothy P LaBranche, Cynthia L Hickman-Brecks, Debra M Meyer, Chad E Storer, Michael I Jesson

Am J Pathol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
14-deoxyandrographolide as a platelet activating factor antagonist in bovine neutrophils.
Rafael A Burgos, María A Hidalgo, Juan Monsalve, Timothy P LaBranche, Peter Eyre

Planta Med· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-activating factor increases pH(i) in bovine neutrophils through the PI3K-ERK1/2 pathway.
María A Hidalgo, Flavio Ojeda, Peter Eyre, Timothy P LaBranche, Carlos Smith

Br J Pharmacol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of 14-deoxyandrographolide on calcium-mediated rat uterine smooth muscle contractility.
Rafael A Burgos, Mario Loyola, María A Hidalgo, Timothy P Labranche, Juan L Hancke

Phytother Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis